Analysts have been eager to weigh in on the Healthcare sector with new ratings on Siemens Healthineers AG (SEMHF – Research Report), Calliditas Therapeutics (CALT – Research Report) and Sanofi (SNYNF – Research Report).
Siemens Healthineers AG (SEMHF)
Kepler Capital analyst William Mackie maintained a Hold rating on Siemens Healthineers AG on February 1 and set a price target of EUR54.00. The company’s shares closed last Thursday at $58.20.
According to TipRanks.com, Mackie is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Siemens Healthineers AG with a $64.24 average price target.
See today’s best-performing stocks on TipRanks >>
Calliditas Therapeutics (CALT)
Kepler Capital analyst Jon Berggren maintained a Buy rating on Calliditas Therapeutics on February 1 and set a price target of SEK150.00. The company’s shares closed last Friday at $20.85.
Berggren has an average return of
According to TipRanks.com, Berggren is ranked #7580 out of 8694 analysts.
Calliditas Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $40.85.
Sanofi (SNYNF)
Kepler Capital analyst David Evans maintained a Hold rating on Sanofi on February 1 and set a price target of EUR92.00. The company’s shares closed last Thursday at $96.59.
Evans has an average return of
According to TipRanks.com, Evans is ranked #4642 out of 8694 analysts.
Sanofi has an analyst consensus of Moderate Buy, with a price target consensus of $99.11, implying a 2.6% upside from current levels. In a report issued on January 23, J.P. Morgan also maintained a Hold rating on the stock with a EUR92.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SEMHF:
